A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
Clinical trial NCT03639194 · COMPLETED
Trial details
- NCT number
- NCT03639194
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2024-01-25
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.